5-methoxytryptophan has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fang, L; Kong, R; Que, J | 1 |
1 other study(ies) available for 5-methoxytryptophan and Pulmonary Fibrosis
| Article | Year |
|---|---|
Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Cell Differentiation; Extracellular Matrix; Gene Expression Regulation; Humans; Lung; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Smad3 Protein; Transforming Growth Factor beta; Tryptophan | 2020 |